Antibodies under a microscope

PX-TA1253

Enavatuzumab Biosimilar – Anti-TNFRSF12A/ CD266 mAb – Research Grade

Description

Enavatuzumab Biosimilar - Anti-TNFRSF12A/ CD266 mAb - Research Grade

Target

TNFRSF12A/ CD266

Target Alias Name

Enavatuzumab/PDL 192/TNFRSF12A/ CD266/anti-TNFRSF12A/ CD266

Isotype/Mimetic

IgG1-kappa

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression